IDO1 and cancer: Recent reports have shown that the established cancer biomarker indoleamine-2,3-dioxygenase 1 (IDO1), which is overexpressed in cancer microenvironments, increases the conversion of tryptophan (Trp) to kynurenine (Kyn)10–12.